Varifarma’s commitment to PORTFOLIO DEVELOPMENT and CONTINUOUS QUALITY IMPROVEMENT has propelled the company toward exceptional and unceasing growth. We are constantly DRIVEN BY NEW CHALLENGES that strengthen our path toward the future.
the medical and scientific communities, as well as for our focus on innovation and the continuous improvement of our production areas and processes. These are supported by rigorous control procedures that meet the highest national and international quality standards.
product registrations worldwide
product registrations across LATAM
An innovative oral therapy for advanced prostate cancer, now expanding across the region.
We are expanding our portfolio with another product for the treatment of HER2+ breast cancer.
A year driven by innovation and portfolio expansion to bring new therapeutic alternatives across the region.
Varifarma at the XXIV Clinical Infectology Conference to support medical education.
Connecting professionals across borders to advance healthcare.
Scientific collaboration and innovative solutions for complex infectious diseases
A commitment to scientific advancement and knowledge exchange for the benefit of patients.
A shared commitment to innovation, excellence, and scientific progress in oncology.
Breakthroughs in pulmonary hypertension, heart failure and cardiometabolism marked this year’s congress in Madrid.
Advances in women’s health and new therapeutic approaches at Argentina’s leading gynecology congress.
At the XVIII Argentine Congress on Controversies in Obstetrics and Gynecology, science and innovation came together to advance women’s health.
We remain committed to advancing our mission of offering broader and more effective therapeutic options for patients with Pulmonary Hypertension.
Contributing to scientific dialogue and advancing clinical practice in infectiology.
